Cochrane Abstracts
A therapeutic‐only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation Edited (no change to conclusions)
A therapeutic‐only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation Edited (no change to conclusions) is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"A Therapeutic‐only Versus Prophylactic Platelet Transfusion Strategy for Preventing Bleeding in Patients With Haematological Disorders After Myelosuppressive Chemotherapy or Stem Cell Transplantation Edited (no Change to Conclusions)." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439382/all/A_therapeutic���only_versus_prophylactic_platelet_transfusion_strategy_for_preventing_bleeding_in_patients_with_haematological_disorders_after_myelosuppressive_chemotherapy_or_stem_cell_transplantation_Edited__no_change_to_conclusions_. Accessed 27 March 2023.
A therapeutic‐only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation Edited (no change to conclusions). Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439382/all/A_therapeutic���only_versus_prophylactic_platelet_transfusion_strategy_for_preventing_bleeding_in_patients_with_haematological_disorders_after_myelosuppressive_chemotherapy_or_stem_cell_transplantation_Edited__no_change_to_conclusions_. Accessed March 27, 2023.
A therapeutic‐only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation Edited (no change to conclusions). In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/439382/all/A_therapeutic���only_versus_prophylactic_platelet_transfusion_strategy_for_preventing_bleeding_in_patients_with_haematological_disorders_after_myelosuppressive_chemotherapy_or_stem_cell_transplantation_Edited__no_change_to_conclusions_
A Therapeutic‐only Versus Prophylactic Platelet Transfusion Strategy for Preventing Bleeding in Patients With Haematological Disorders After Myelosuppressive Chemotherapy or Stem Cell Transplantation Edited (no Change to Conclusions) [Internet]. In: Cochrane Abstracts. [cited 2023 March 27]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439382/all/A_therapeutic���only_versus_prophylactic_platelet_transfusion_strategy_for_preventing_bleeding_in_patients_with_haematological_disorders_after_myelosuppressive_chemotherapy_or_stem_cell_transplantation_Edited__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - A therapeutic‐only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation Edited (no change to conclusions)
ID - 439382
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439382/all/A_therapeutic���only_versus_prophylactic_platelet_transfusion_strategy_for_preventing_bleeding_in_patients_with_haematological_disorders_after_myelosuppressive_chemotherapy_or_stem_cell_transplantation_Edited__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -
